Glimepiride Tablets recall
FDA recall D-0313-2024 · initiated Jan 18, 2024
Dr. Reddy's Laboratories, Inc. recalled Glimepiride Tablets in Jan 2024 — an FDA Class III recall (D-0313-2024) because Misprint on tablet.
Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
Why it was recalled
Misprint on tablet
Labelling, packaging or a product mix-up
The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 14,425 bottles
Details
- Product
- Glimepiride Tablets, USP 1mg, 500-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-05
- Recalling company
- Dr. Reddy's Laboratories Limited
- Classification
- Class III
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide
- Initiated
- Jan 18, 2024
- FDA report date
- Feb 14, 2024
This recall is linked to a product we cover: Glimepiride →
Frequently asked
- Was Glimepiride Tablets recalled?
- Dr. Reddy's Laboratories, Inc. recalled Glimepiride Tablets in Jan 2024 — an FDA Class III recall (D-0313-2024) because Misprint on tablet. Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
- Why was Glimepiride Tablets recalled?
- Per the FDA enforcement record, the reason for recall D-0313-2024 was: Misprint on tablet
- Is a recalled Glimepiride Tablets dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Unlikely to cause harm but violates FDA labeling or manufacturing regulations. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Glimepiride Tablets are affected?
- Distributed: Nationwide. The recall covers these lots — Lot: T2303609; Exp. 06/2026 Lot: T2303610; Exp. 06/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0313-2024.